MIMS Mental Health Clinic

Latest news and quick-reference resources collated by the MIMS editors to support primary care prescribing for mental health conditions, including depression, schizophrenia and Alzheimer's disease.

Latest news

Mirtazapine no more effective than placebo as an additive antidepressant

Mirtazapine no more effective than placebo as an additive antidepressant

Mirtazapine is unlikely to provide any clinical benefit...

Gabapentin and pregabalin to be subject to tighter controls

Gabapentin and pregabalin to be subject to tighter controls

From April 2019 gabapentin and pregabalin will be reclassified...

Antidepressant withdrawal 'much greater problem than guidelines suggest'

Antidepressant withdrawal 'much greater problem than guidelines suggest'

The incidence, severity and duration of antidepressant...

New atypical antipsychotic offers potential benefits in treatment of schizophrenia

New atypical antipsychotic offers potential benefits in treatment of schizophrenia

Reagila (cariprazine) is an orally active partial agonist...


Prescribing Notes

Guide to treatment options for selected mental health conditions:

Depression (including SSRIs/SNRIs, MAO inhibitors and tricyclic antidepressants)

Anxiety (including benzodiazepines and beta-blockers)

Psychosis, mania (including phenothiazines, atypical antipsychotics and lithium)

Alcohol dependence (including disulfiram)

Opiate dependence (including buprenorphine)


At-a-glance product comparison charts.


Summaries of key national guidance.



From our sister sites

CPD from 

Articles from


Calculators

Promo Image

Cardiovascular risk (JBS3)

Enter details of patient's risk factors to calculate the risk of cardiovascular disease.

Promo Image

Physical activity (GPPAQ)

Enter patient’s questionnaire responses to assess physical activity levels.

This site is intended for healthcare professionals.